Page last updated: 2024-10-18

5,6-dihydroorotate and Diabetes Mellitus, Gestational

5,6-dihydroorotate has been researched along with Diabetes Mellitus, Gestational in 1 studies

4,5-dihydroorotic acid: RN given refers to cpd without isomeric designation; structure
dihydroorotic acid : A pyrimidinemonocarboxylic acid that results from the base-catalysed cyclisation of N(alpha)-carbethoxyasparagine.

Research Excerpts

ExcerptRelevanceReference
"Aberrant fetal programming in gestational diabetes mellitus seems to increase the risk of obesity, type 2 diabetes, and cardiovascular disease."1.62Early pregnancy metabolites predict gestational diabetes mellitus: implications for fetal programming. ( Gornbein, JA; Koos, BJ, 2021)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Koos, BJ1
Gornbein, JA1

Other Studies

1 other study available for 5,6-dihydroorotate and Diabetes Mellitus, Gestational

ArticleYear
Early pregnancy metabolites predict gestational diabetes mellitus: implications for fetal programming.
    American journal of obstetrics and gynecology, 2021, Volume: 224, Issue:2

    Topics: Adult; Alanine; Arginine; Carnitine; Case-Control Studies; Diabetes, Gestational; Diet Therapy; Dopa

2021